If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Junji Kishimoto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Japan Medicine & Life Sciences
Carotid Intima-Media Thickness Medicine & Life Sciences
Amlodipine Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 2424 Citations
  • 22 h-Index
  • 95 Article
  • 2 Comment/debate
  • 1 Review article

Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor–tyrosine kinase inhibitors

Iwama, E., Sakai, K., Hidaka, N., Inoue, K., Fujii, A., Nakagaki, N., Ota, K., Toyozawa, R., Azuma, K., Nakatomi, K., Harada, T., Hisasue, J., Sakata, S., Shimose, T., Kishimoto, J., Nakanishi, Y., Nishio, K. & Okamoto, I., Jan 1 2019, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Epidermal Growth Factor
Phosphotransferases
DNA
Protein-Tyrosine Kinases

Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)

Fukuda, M., Kitazaki, T., Ogawara, D., Ichiki, M., Mukae, H., Maruyama, R., Nakagaki, N., Shimada, M., Ikeda, T., Kishimoto, J., Harada, T., Seto, T., Ebi, N., Takayama, K., Okamoto, I., Ichinose, Y. & Sugio, K., Jun 1 2019, In : Lung Cancer. 132, p. 1-8 8 p.

Research output: Contribution to journalArticle

Pemetrexed
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Disease-Free Survival
Bevacizumab

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer

Mori, H., Kubo, M., Kai, M., Yamada, M., Kurata, K., Kawaji, H., Kaneshiro, K., Osako, T., Nishimura, R., Arima, N., Okido, M., Kishimoto, J., Oda, Y. & Nakamura, M., Aug 15 2019, In : Breast Cancer Research and Treatment. 176, 3, p. 569-577 9 p.

Research output: Contribution to journalArticle

Open Access
Triple Negative Breast Neoplasms
Lymphocytes
Survival
Tumor-Infiltrating Lymphocytes
Neoplasms
3 Citations (Scopus)

A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors

Hijikata, Y., Okazaki, T., Tanaka, Y., Murahashi, M., Yamada, Y., Yamada, K., Takahashi, A., Inoue, H., Kishimoto, J., Nakanishi, Y., Oda, Y., Nakamura, Y. & Tani, K., Jan 1 2018, In : PloS one. 13, 1, e0187878.

Research output: Contribution to journalArticle

Clinical Trials, Phase I
cyclophosphamide
Cell- and Tissue-Based Therapy
Cyclophosphamide
Fingers

A rightward saccade to an unexpected stimulus as a marker for lateralised visuospatial attention /631/378/2649/1310 /631/378/2617/1795 /631/477/2811 article

Sanefuji, M., Yamashita, H., Torio, M., Katsuki, D., Akamine, S., Ishizaki, Y., Kishimoto, J., Sakai, Y., Takada, H., Yoshida, K. & Ohga, S., Dec 1 2018, In : Scientific reports. 8, 1, 7562.

Research output: Contribution to journalArticle

Saccades
Reaction Time
Task Performance and Analysis
Healthy Volunteers
Brain